| 查看: 1261 | 回复: 4 | |||
| 本帖产生 1 个 翻译EPI ，点击这里进行查看 | |||
[交流]
急。求助翻译。质量一般就行，不要机译。谢谢
|
|||
|
The objective of the present study was to employ suitable adsorbent with free flowing characteristicsfor improving the stability and physical properties of solid lipid nanoparticles (SLN) for oral administration. Stearic acid based nanoparticles of carvedilol phosphate were fabricated by solvent emulsification evaporation technique in sodium taurocholate solution prepared in pH 7.2 buffers (I—KH2PO4/NaOH or II—NaH2PO4/Na2HPO4) with 1% polyvinyl alcohol. Nanoparticles were then adsorbed by passing the nanodispersion through a Neusilin US2 (adsorbent) column. Interestingly, scanning electron microscopy revealed round deformed and even collapsed nanoparticles in Buffer-I and discrete spherical to ellipsoidal nanoparticles in Buffer-II which indicates the inability of nanoemulsion to crystallize and form SLN in Buffer-I. The successful formation of SLN in Buffer-II was confirmed by differential scanning calorime try and X-ray diffraction. The retention of SLN from the nanodispersion by adsorption on the adsorbent imparted good flow property and resulted in a marked stability improvement of the formulation in terms of drug retention efficiency and release profile as compared to the simple nanosuspension. In conclusion, the adsorbent technology would be instrumental in imparting additional features to the existing conventional colloidal system for pharmaceutical application which would ease the process of capsule filling at industrial scale, simplify the handling of formulations by patients and can significantly improve the shelf life of the product for a longer period of time as compared to liquid formulations. improve stability. However, the coexistence of high concentration of stabilizing agents (surfactants) along with the lipid nanopartiSolid lipid based colloidal carriers of drugs have attracted considerable attention in the last two decades [1–4]. As they are derived from physiologically compatible lipids, solid lipid nanoparticles (SLN) represent a safe and effective alternative which include additional advantages and are devoid of the potential toxicities of conventional polymeric nanoparticles [5–7]. SLN for oral drug administration have specifically been employed for improving bioavailability by targeting the uptake of the drug by lymphatic system which prevents its hepatic first pass metabolism [8–11]. Despite the perceived therapeutic advantages of SLN, the technology available so far for the fabrication of SLN is restricted to the development of nanodispersion which has not had been so encouraging. In an aqueous nanodispersion, the SLN have a tendency to undergo particle aggregation under accelerated storage conditions due to the gelation phenomenon (an irreversible conversion of low viscosity lipid based nanoparticles dispersion into a viscous gel) due to which the dispersion is usually lyophilized into a dry powder to cles (LNs) in the final product is not desirable because of their toxic effects on the mucosal lining of the GIT. Moreover, the process of lyophilization is critical as rate of freezing governs the structure and properties of the lipid crystals which finally determines its drug retention capacity during storage. Alternatively, filtration of the nanoparticles as a whole is a costly and exhaustive process due to the requirement of sophisticated equipments for retaining particles in nanosize range. Apart from the above, surfactants essentially employed in the production of SLN increase solubility of the poorly soluble/insoluble drug in the external phase. This matter is of serious concern during production and upon long term storage as it results in progressive leaching of drug from the particles to external phase which results in reduced drug loading efficiency. The above issues have been discussed in detail in literature [12].The above discussion indicates that there is a necessity to develop a method which can separate the nanoparticles from the dispersion and immobilize them in order to retain their individual morphological identity upon storage. Harvesting the SLN from the nanodispersion by surface adsorption or retention on a submicron size inert pharmaceutical excipient with good flowability, compressibility and adsorption capacity may be an excellent approach to overcome the above mentioned issues. The prepared “Adsorbed Lipid Nanoparticles” (ALN) would not only maintain the integrity of each adsorbed nanoparticle but also ease its filling into capsules or compression into tablet. To our knowledge, such a unique approach in the development of SLN delivery system has not been reported so far. However, limited studies involving the use of adsorbents to obtain lipid based granules for oral drug delivery have been reported wherein adsorbents were found to enhance the bioavailability of the drug and impart significant flow and compressibility to the final blend [13–15].The drug employed here is carvedilol phosphate, a non-selective-blocker. The drug exhibits poor aqueous solubility and highlipophilicity (log P) which makes it an excellent candidate for SLN encapsulation[16,17]. A study conducted previously in our laboratory using different types and concentration of surfactants at different pH has shown that sodium taurocholate (STC) has both minimum molar solubilization capacity and binding constant for carvedilol phosphate at pH 7.2 [18]. Therefore, the objective of the present work was to develop SLN of carvedilol phosphate using STC as a stabilizing agent and pH 7.2 phosphate buffer as dispersion medium, and improve the physicochemical properties of the nanoparticles by adsorbing them onto Neusilin (magnesium aluminometasilicate), an inert pharmaceutical excipient used as adsorbent. 2. Materials and methods [ Last edited by kaichang on 2011-1-9 at 13:15 ] |
回复此楼» 猜你喜欢
268求调剂
已经有7人回复
-
一志愿重庆大学085700资源与环境总分308求调剂
已经有4人回复
-
302求调剂
已经有11人回复
-
306求调剂
已经有4人回复
-
材料学学硕080502 337求调剂-一志愿华中科技大学
已经有4人回复
-
求调剂
已经有6人回复
-
313求调剂
已经有3人回复
-
南昌大学材料专硕311分求调剂
已经有6人回复
-
316求调剂
已经有6人回复
-
346求调剂[0856]
已经有7人回复
» 抢金币啦！回帖就可以得到:
-
中国科学院杭州医学研究-常皓研究员课题组博士后招聘
+1/281
-
农业信息工程技术（专硕）招收调剂 沈阳农业大学
+1/184
-
浙江大学侯阳教授团队诚聘博士后---高性能固态电解质与固态电池器件设计
+1/84
-
散金币，求基金中标！！
+1/61
-
0854电子信息调剂，闽南师大光电芯片研发实验室，柯少颖教授课题组，集成电路
+1/35
-
1
+1/32
-
上海交通大学电催化方向博后招聘-有锂电、高分子、燃料电池背景者优先
+1/31
-
从专科一路到211硕士，到TOP5博士，也想进高校体制
+1/31
-
研究生 调剂 看过来- 机械、控制工程、力学类（流体力学、一般力学等） 211 双一流
+1/29
-
中山大学院士团队微纳器件、脑机接口方向博士招生、博后招聘
+1/18
-
湖南大学微生物结构与功能实验室2026年计划招收博士研究生
+1/18
-
海南师范大学孙元元老师招生博士，名额1~2个，2026年9月份入学（光电/光热催化方向）
+1/17
-
临沂大学数学与统计学院招2026研究生
+1/17
-
丽水学院 材料与能源工程学院 陈江飞老师课题组硕士招生----材料与化工专业
+1/16
-
【2026博士招生/博后招聘】北京航空航天大学潘彪课题组——AI芯片设计方向
+1/11
-
调剂 22408 340分
+1/9
-
青岛科技大学化工学院院士团队2026年拟招收全日制博士研究生1名
+1/8
-
北京高校副校长团队招收机械类，环境类学硕和专硕
+1/5
-
昆明理工大学陈江照教授团队博士招生
+1/4
-
2026考研的同学，分数不够？想调剂上岸的同学，来看
+1/2
kaichang(金币+2, 翻译EPI+1):尽管只有一句，不过还是谢谢。有空就全部帮我翻译了吧。 2011-01-09 18:51:36
|
The objective of the present study was to employ suitable adsorbent with free flowing characteristics for improving the stability and physical properties of solid lipid nanoparticles (SLN) for oral administration. 本文的目的是采用能自由流动的吸附剂，来改善作口服剂之用的固体脂质纳米粒的稳定性与物理性能。 |
2楼2011-01-09 17:21:15
|
The objective of the present study was to employ suitable adsorbent with free flowing characteristicsfor improving the stability and physical properties of solid lipid nanoparticles (SLN) for oral administration. Stearic acid based nanoparticles of carvedilol phosphate were fabricated by solvent emulsification evaporation technique in sodium taurocholate solution prepared in pH 7.2 buffers (I—KH2PO4/NaOH or II—NaH2PO4/Na2HPO4) with 1% polyvinyl alcohol. 本文的目的是采用能自由流动的吸附剂，来改善作口服剂之用的固体脂质纳米粒的稳定性与物理性能。基于卡维地洛磷酸盐的硬脂酸是由溶剂乳化蒸发技术制得，该过程是在1%的聚乙烯醇产生的ph值为7.2的缓冲池中制备的牛黄胆酸钠中完成的。 |
3楼2011-01-09 18:51:08
4楼2011-01-10 00:05:25
5楼2011-01-10 01:12:07
